|
|
|
Volumn 29, Issue 2, 1996, Pages 129-144
|
|
Selective α1-adrenoceptor antagonists in benign prostatic hyperplasia: Rationale and clinical experience
|
|
Author keywords
1 adrenoceptor subtypes; Benign prostatic hyperplasia, review; Selective 1 adrenoceptor antagonist; Subtype specific 1 adrenoceptor antagonists
|
|
Indexed keywords
ALFUZOSIN;
ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT;
DOXAZOSIN;
INDORAMIN;
PHENOXYBENZAMINE;
PRAZOSIN;
TAMSULOSIN;
TERAZOSIN;
ASTHENIA;
DIARRHEA;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG TOLERANCE;
EDEMA;
FATIGUE;
HEADACHE;
HEART PALPITATION;
HUMAN;
IMPOTENCE;
INFLUENZA;
LASSITUDE;
MALE;
NAUSEA;
NOSE CONGESTION;
ORTHOSTATIC HYPOTENSION;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
RETROGRADE EJACULATION;
REVIEW;
RHINITIS;
SOMNOLENCE;
SYNCOPE;
TACHYCARDIA;
THORAX PAIN;
URINE FLOW RATE;
VERTIGO;
ADRENERGIC ALPHA-ANTAGONISTS;
BLOOD PRESSURE;
CLINICAL TRIALS;
DOXAZOSIN;
HALF-LIFE;
HUMANS;
MALE;
PRAZOSIN;
PROSTATIC HYPERPLASIA;
SULFONAMIDES;
VASODILATION;
|
|
EID: 0030046158
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (135)
|
|
References (0)
|
